For most of my adult life (before cancer), I mistakenly believed that clinical trials were the pathway of last resort for cancer patients who had failed to achieve remission via conventional therapies and were left with no alternatives. I was wrong. There have been so many advances in recent years from monoclonal antibodies to cell signalling pathway activators and inhibitors. Genetic testing is giving doctors and researchers the data they need to target therapies more precisely with less toxicity and treatment side effects. In my case, existing chemotherapies are not known to very effective in stopping the advancing state of this leukemia variant (mutation). Cancer treatment is becoming very individualized and clinical trials are delivering the future in cancer care today. Please give Dr. Tom Lynch a listen.
BTW, I’m a 3%’er 🙂